Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ANGPTL8 has both endocrine and autocrine effects on substrate utilization
Federico Oldoni, Haili Cheng, Serena Banfi, Viktoria Gusarova, Jonathan C. Cohen, Helen H. Hobbs
Federico Oldoni, Haili Cheng, Serena Banfi, Viktoria Gusarova, Jonathan C. Cohen, Helen H. Hobbs
View: Text | PDF
Research Article Endocrinology Metabolism

ANGPTL8 has both endocrine and autocrine effects on substrate utilization

  • Text
  • PDF
Abstract

The angiopoietin-like protein ANGPTL8 (A8) is one of 3 ANGPTLs (A8, A3, A4) that coordinate changes in triglyceride (TG) delivery to tissues by inhibiting lipoprotein lipase (LPL), an enzyme that hydrolyzes TG. Previously we showed that A8, which is expressed in liver and adipose tissue, is required to redirect dietary TG from oxidative to storage tissues following food intake. Here we show that A8 from liver and adipose tissue have different roles in this process. Mice lacking hepatic A8 have no circulating A8, high intravascular LPL activity, low plasma TG levels, and evidence of decreased delivery of dietary lipids to adipose tissue. In contrast, mice lacking A8 in adipose tissue have higher postprandial TG levels and similar intravascular LPL activity and plasma A8 levels and higher levels of plasma TG. Expression of A8, together with A4, in cultured cells reduced A4 secretion and A4-mediated LPL inhibition. Thus, hepatic A8 (with A3) acts in an endocrine fashion to inhibit intravascular LPL in oxidative tissues, whereas A8 in adipose tissue enhances LPL activity by autocrine/paracrine inhibition of A4. These combined actions of A8 ensure that TG stores are rapidly replenished and sufficient energy is available until the next meal.

Authors

Federico Oldoni, Haili Cheng, Serena Banfi, Viktoria Gusarova, Jonathan C. Cohen, Helen H. Hobbs

×

Figure 5

Plasma lipid and glucose levels, postheparin plasma lipase activities, and intravascular LPL levels in mice of the indicated genotypes.

Options: View larger image (or click on image) Download as PowerPoint
Plasma lipid and glucose levels, postheparin plasma lipase activities, a...
(A) Diets of age-matched male mice (n = 5–6/group, 10–15 weeks) were synchronized as described in the Methods. Plasma samples were obtained at the end of the last fasting period (Fasting) and then 4 hours after refeeding (Fed), and levels of TGs, nonesterified fatty acids (NEFAs) and (B) cholesterol were measured in duplicate (5 μL). Plasma glucose levels were measured from the first drop of blood from the tail vein. Values are shown as means (± SEM). The experiment was repeated and the data were similar. Groups were compared using 2-way ANOVA. *P < 0.05; **P < 0.01; ****P < 0.0001. The experiment was performed 3 times and the compiled results are shown. (C) The diets of the mice were handled as described in panel A. Four hours after refeeding, blood was collected from the WT mice. Mice were then injected with heparin intravenously (1 U/g), and blood was collected after 15 minutes. Pooled plasma was fractionated on a heparin column (1 mL) to separate hepatic lipase (HL) and LPL. TG lipase activity was measured in each fraction as described in Methods. Pooled plasma samples (10 μL) were diluted to 500 μL with PBS and incubated with heparin beads (20 μL) for 2 hours. The heparin bead–bound proteins were subjected to immunoblotting using anti-mouse LPL and HL polyclonal antibodies, as described in the Methods. Quantitative values are expressed as ratios to the level of HL and expressed relative to the WT value, which was set to 1.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts